Hipertrófiás kardiomiopátia: vizsgálatok itt: Lengyelország
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
- Where
- Katowice, Warsaw, Wrocław
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 - 2. fázisTaking peopleA Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Where
- Katowice, Warsaw, Wroclaw
- Életkor
- 18 év and over
- People
- 165 worldwide
- Run by
- Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614 - 2/3. fázisTaking peopleOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- Katowice, Warsaw
- Életkor
- 18 év to 85 év
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00 - No phaseVisszavonvaA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Katowice, Warsaw
- Életkor
- 18 év and over
- People
- 1700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705 - 2. fázisTaking peopleMEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies
- Where
- Warsaw
- Életkor
- 1 nap to 18 év
- People
- 40
- Run by
- Medical University of Warsaw
See details and how to joinNCT06555237